Saatchi reportedly wins Levitra DTC work

Share this article:

The Saatchi & Saatchi Consumer Healthcare unit of Publicis Groupe has won the creative duties for Levitra, AdWeek.com reported late Thursday.
Levitra, which is now co-promoted by Schering-Plough and GlaxoSmithKline, has been in review for the past several weeks.
CommonHealth's Quantum previously held the account, but was not listed among the groups who were pitching. A spokeswoman for CommonHealth declined to comment to MM&M about the review this week
Estimated billings are $90 million.
The other finalists were Omnicom Group shops BBDO and Merkley + Partners, both in New York, according to AdWeek. DDB, another Omnicom shop, initially pursued the business but withdrew before final presentations, the report stated.
Bayer and GSK co-promoted Levitra since its launch in 2003, but earlier this year Bayer agreed to turn over marketing rights for most of its prescription drug products to Schering-Plough.
Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.